Industry Supported Sessions

​​​​monday, november 30, 2015 

INDUSTRY SESSION SUPPORTED BY STEALTH BIO THERAPEUTICS

13:00-14:00
Targeting Mitochondria for Treatment in Cardiology

Chairman: Basil S. Lewis, Israel 

Rationale and Initial Clinical Results in Heart Failure
Hani N. Sabbah, USA

Lessons from EMBRACE STEMI
Ingo Ahrens, Germany

New Concepts in Clinical Development for Heart Failure
Mihai Gheorghiade, USA 

 

TUESDAY, DECEMBER 1, 2015 ​

INDUSTRY SESSION SUPPORTED BY SANOFI AND REGENERON
13:00-14:00 
PCSK9 Inhibitors: New Solutions for High Cardiovascular Risk Patients with Hypercholesterolemia

Chairman: Michele Gulizia, Italy

Who are the Hypercholesterolemic Patients with the Highest Need for More Lipid Lowering?
Michel Farnier, France 

What can we Expect from the New PCSK9 Inhibitors?
Norman Lepor, USA


Keep Me Updated